Clinical Trials Directory

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited blistering disease caused by the absence of type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening RDEB subjects to determine additional characteristics of patients who survive to adulthood.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.


Phase: N/A


Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

1. Clinical diagnosis of RDEB by local dermatologist. 2. 18 years of age or more and willing to give consent.

External Links

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Emily Gorell, MS
Not Recruiting

Footer Links: